1. Zhu, Dan, Xu, Ruidan, Huang, Xinping, Zhang, Jinfang, Zheng, Xiaofeng. 2020. Deubiquitinating enzyme OTUB1 promotes cancer cell immunosuppression via preventing ER-associated degradation of immune checkpoint protein PD-L1. In Cell death and differentiation, 28, 1773-1789. doi:10.1038/s41418-020-00700-z. https://pubmed.ncbi.nlm.nih.gov/33328570/
2. Peng, Liqun, Wu, Tiangen, Liu, Yingyi, He, Wenzhi, Yuan, Yufeng. 2024. OTUB1 accelerates hepatocellular carcinoma by stabilizing RACK1 via its non-canonical ubiquitination. In Cellular oncology (Dordrecht, Netherlands), 47, 987-1004. doi:10.1007/s13402-023-00913-7. https://pubmed.ncbi.nlm.nih.gov/38315284/
3. Xu, Fei, Zang, Tongtong, Chen, Han, Qian, Juying, Ge, Junbo. 2023. Deubiquitinase OTUB1 regulates doxorubicin-induced cardiotoxicity via deubiquitinating c-MYC. In Cellular signalling, 113, 110937. doi:10.1016/j.cellsig.2023.110937. https://pubmed.ncbi.nlm.nih.gov/37871668/
4. Zhang, Wenhao, Qiu, Wenlong. 2020. OTUB1 Recruits Tumor Infiltrating Lymphocytes and Is a Prognostic Marker in Digestive Cancers. In Frontiers in molecular biosciences, 7, 212. doi:10.3389/fmolb.2020.00212. https://pubmed.ncbi.nlm.nih.gov/33240928/
5. Wang, Di, Li, Yongge, Chang, Weilong, Liu, Zhibo, Fu, Yang. 2024. CircSEC24B activates autophagy and induces chemoresistance of colorectal cancer via OTUB1-mediated deubiquitination of SRPX2. In Cell death & disease, 15, 693. doi:10.1038/s41419-024-07057-y. https://pubmed.ncbi.nlm.nih.gov/39333496/
6. Zhao, Xuefeng, Lv, Suli, Li, Neng, Sun, Lidong, Song, Tanjing. 2024. YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation. In The Journal of biological chemistry, 300, 107152. doi:10.1016/j.jbc.2024.107152. https://pubmed.ncbi.nlm.nih.gov/38462165/
7. Liu, Zhenchuan, Wang, Tingting, She, Yunlang, Chen, Chang, Zhou, Yongxin. 2021. N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. In Molecular cancer, 20, 105. doi:10.1186/s12943-021-01398-4. https://pubmed.ncbi.nlm.nih.gov/34416901/
8. Wang, Juanjuan, Liu, Yuting, Wu, Di, Liu, Li, Zeng, Yulan. 2024. OTUB1 Targets CHK1 for Deubiquitination and Stabilization to Facilitate Lung Cancer Progression and Radioresistance. In International journal of radiation oncology, biology, physics, 119, 1222-1233. doi:10.1016/j.ijrobp.2024.01.202. https://pubmed.ncbi.nlm.nih.gov/38266782/
9. Mulas, Floriana, Wang, Xu, Song, Shanshan, Deckert, Martina, Schlüter, Dirk. 2020. The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13. In Cellular & molecular immunology, 18, 1512-1527. doi:10.1038/s41423-020-0362-6. https://pubmed.ncbi.nlm.nih.gov/32024978/
10. Li, Shangxuan, Yang, Meng, Zhao, Yinfeng, Pan, Zhenwei, Lu, Yanjie. 2024. Deletion of ASPP1 in myofibroblasts alleviates myocardial fibrosis by reducing p53 degradation. In Nature communications, 15, 8425. doi:10.1038/s41467-024-52739-y. https://pubmed.ncbi.nlm.nih.gov/39341821/